CNBC's Aditi Roy reports on Juul filing a lawsuit against copycat competitors and how the e-cig company is starting to hurt big tobacco stocks.
Christi Shaw, Lilly Bio-Medicines president, discusses the FDA approving Eli Lilly's new migraine drug, Emgality.
Tony Abboud, Vapor Technology Association executive director, and Dave Dobbins, Truth Initiative COO, debate the seriousness of teenage e-cigarette and vaping product use.
Dr. John Torres, NBC medical correspondent, reports the latest figures on teenage e-cigarette and vaping product use as the FDA calls it an "epidemic."
CNBC's 'Squawk Box' team discusses the increase of teens vaping and the FDA's plan to stop it.
Michael Lavery, Piper Jaffray analyst, discusses the implications for tobacco companies as the FDA cracks down on e-cigarettes that are appealing to teenagers.
The FDA said it cannot tolerate "a whole generation of young people becoming addicted to nicotine as a trade off for enabling adults to access these products," and so it has launched a crackdown on sales of e-cigarettes to teens.